Lan Huang1,2, Colette Bichsel1,2, Alexis L Norris3, Jeremy Thorpe3, Jonathan Pevsner3, Sanda Alexandrescu4, Anna Pinto5, David Zurakowski6, Robin J Kleiman5, Mustafa Sahin5, Arin K Greene7,8, Joyce Bischoff1,2. 1. Vascular Biology Program (L.H., C.B., J.B.), Boston Children's Hospital and Harvard Medical School, MA. 2. Department of Surgery (L.H., C.B., J.B.), Boston Children's Hospital and Harvard Medical School, MA. 3. Department of Neurology, Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, MD (A.L.N., J.T., J.P.). 4. Department of Pathology (S.A.), Boston Children's Hospital and Harvard Medical School, MA. 5. Department of Neurology (A.P., R.J.K., M.S.), Boston Children's Hospital and Harvard Medical School, MA. 6. Department of Anesthesiology, Critical Care and Pain Medicine Research (D.Z.), Boston Children's Hospital and Harvard Medical School, MA. 7. Department of Plastic and Oral Surgery (A.K.G.), Boston Children's Hospital and Harvard Medical School, MA. 8. Vascular Anomalies Center (A.K.G.), Boston Children's Hospital and Harvard Medical School, MA.
Abstract
OBJECTIVE: Capillary malformation (CM) occurs sporadically and is associated with Sturge-Weber syndrome. The somatic mosaic mutation in GNAQ (c.548G>A, p.R183Q) is enriched in endothelial cells (ECs) in skin CM and Sturge-Weber syndrome brain CM. Our goal was to investigate how the mutant Gαq (G-protein αq subunit) alters EC signaling and disrupts capillary morphogenesis. Approach and Results: We used lentiviral constructs to express p.R183Q or wild-type GNAQ in normal human endothelial colony forming cells (EC-R183Q and EC-WT, respectively). EC-R183Q constitutively activated PLC (phospholipase C) β3, a downstream effector of Gαq. Activated PLCβ3 was also detected in human CM tissue sections. Bulk RNA sequencing analyses of mutant versus wild-type EC indicated constitutive activation of PKC (protein kinase C), NF-κB (nuclear factor kappa B) and calcineurin signaling in EC-R183Q. Increased expression of downstream targets in these pathways, ANGPT2 (angiopoietin-2) and DSCR (Down syndrome critical region protein) 1.4 were confirmed by quantitative PCR and immunostaining of human CM tissue sections. The Gαq inhibitor YM-254890 as well as siRNA targeted to PLCβ3 reduced mRNA expression levels of these targets in EC-R183Q while the pan-PKC inhibitor AEB071 reduced ANGPT2 but not DSCR1.4. EC-R183Q formed enlarged blood vessels in mice, reminiscent of those found in human CM. shRNA knockdown of ANGPT2 in EC-R183Q normalized the enlarged vessels to sizes comparable those formed by EC-WT. CONCLUSIONS: Gαq-R183Q, when expressed in ECs, establishes constitutively active PLCβ3 signaling that leads to increased ANGPT2 and a proangiogenic, proinflammatory phenotype. EC-R183Q are sufficient to form enlarged CM-like vessels in mice, and suppression of ANGPT2 prevents the enlargement. Our study provides the first evidence that endothelial Gαq-R183Q is causative for CM and identifies ANGPT2 as a contributor to CM vascular phenotype.
OBJECTIVE: Capillary malformation (CM) occurs sporadically and is associated with Sturge-Weber syndrome. The somatic mosaic mutation in GNAQ (c.548G>A, p.R183Q) is enriched in endothelial cells (ECs) in skin CM and Sturge-Weber syndrome brain CM. Our goal was to investigate how the mutant Gαq (G-protein αq subunit) alters EC signaling and disrupts capillary morphogenesis. Approach and Results: We used lentiviral constructs to express p.R183Q or wild-type GNAQ in normal human endothelial colony forming cells (EC-R183Q and EC-WT, respectively). EC-R183Q constitutively activated PLC (phospholipase C) β3, a downstream effector of Gαq. Activated PLCβ3 was also detected in human CM tissue sections. Bulk RNA sequencing analyses of mutant versus wild-type EC indicated constitutive activation of PKC (protein kinase C), NF-κB (nuclear factor kappa B) and calcineurin signaling in EC-R183Q. Increased expression of downstream targets in these pathways, ANGPT2 (angiopoietin-2) and DSCR (Down syndrome critical region protein) 1.4 were confirmed by quantitative PCR and immunostaining of human CM tissue sections. The Gαq inhibitor YM-254890 as well as siRNA targeted to PLCβ3 reduced mRNA expression levels of these targets in EC-R183Q while the pan-PKC inhibitor AEB071 reduced ANGPT2 but not DSCR1.4. EC-R183Q formed enlarged blood vessels in mice, reminiscent of those found in human CM. shRNA knockdown of ANGPT2 in EC-R183Q normalized the enlarged vessels to sizes comparable those formed by EC-WT. CONCLUSIONS: Gαq-R183Q, when expressed in ECs, establishes constitutively active PLCβ3 signaling that leads to increased ANGPT2 and a proangiogenic, proinflammatory phenotype. EC-R183Q are sufficient to form enlarged CM-like vessels in mice, and suppression of ANGPT2 prevents the enlargement. Our study provides the first evidence that endothelial Gαq-R183Q is causative for CM and identifies ANGPT2 as a contributor to CM vascular phenotype.
Entities:
Keywords:
GTP-binding protein alpha subunits; Sturge-Weber syndrome; angiopoietin-2; endothelial cells; port wine stain
Authors: Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner Journal: N Engl J Med Date: 2013-05-08 Impact factor: 91.245
Authors: Timothy D Le Cras; Paula S Mobberley-Schuman; Mary Broering; Lin Fei; Cameron C Trenor; Denise M Adams Journal: Angiogenesis Date: 2016-12-18 Impact factor: 9.596
Authors: Laura Hakanpaa; Tuomas Sipila; Veli-Matti Leppanen; Prson Gautam; Harri Nurmi; Guillaume Jacquemet; Lauri Eklund; Johanna Ivaska; Kari Alitalo; Pipsa Saharinen Journal: Nat Commun Date: 2015-01-30 Impact factor: 14.919
Authors: Ahmad F Alghanem; Emma L Wilkinson; Maxine S Emmett; Mohammad A Aljasir; Katherine Holmes; Beverley A Rothermel; Victoria A Simms; Victoria L Heath; Michael J Cross Journal: Angiogenesis Date: 2017-03-07 Impact factor: 9.596
Authors: F Galeffi; D A Snellings; S E Wetzel-Strong; N Kastelic; J Bullock; C J Gallione; P E North; D A Marchuk Journal: Angiogenesis Date: 2022-05-30 Impact factor: 10.658